Phillip Pang Vir Biotechnology, Inc. (VIR) insider trading activity

Phillip Pang is EVP & Chief Medical Officer of Vir Biotechnology, Inc.. Currently has a direct ownership of 250,111 shares of VIR, which is worth approximately $2.51 Million. The most recent transaction as insider was on Feb 22, 2024, when has been sold 14,568 shares (Common Stock) at a price of $10.05 per share, resulting in proceeds of $146,408. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 250K

0% 3M change

6.67% 12M change

Total Value Held $2.51 Million

Phillip Pang Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 22 2024	SELL Open market or private sale	$146,408 $10.05 p/Share	14,568 Reduced 5.5%	250,111 Common Stock
Feb 16 2024	SELL Open market or private sale	$34,007 $10.24 p/Share	3,321 Reduced 1.24%	264,679 Common Stock
Jan 02 2024	BUY Exercise of conversion of derivative security	$105,600 $1.32 p/Share	80,000 Added 22.99%	268,000 Common Stock
Jun 07 2023	SELL Open market or private sale	$129,750 $25.95 p/Share	5,000 Reduced 2.59%	188,000 Common Stock
Jun 07 2023	BUY Exercise of conversion of derivative security	$7,650 $1.53 p/Share	5,000 Added 2.53%	193,000 Common Stock
Feb 27 2023	SELL Open market or private sale	$240,249 $23.28 p/Share	10,320 Reduced 5.2%	188,000 Common Stock
Feb 23 2023	SELL Open market or private sale	$74,741 $25.97 p/Share	2,878 Reduced 1.43%	198,320 Common Stock
Feb 22 2023	BUY Grant, award, or other acquisition	-	60,000 Added 22.97%	201,198 Common Stock
Feb 17 2023	SELL Open market or private sale	$70,862 $25.29 p/Share	2,802 Reduced 1.95%	141,198 Common Stock
Jan 24 2023	SELL Open market or private sale	$900,000 $30.0 p/Share	30,000 Reduced 17.24%	144,000 Common Stock
Jan 24 2023	BUY Grant, award, or other acquisition	$101,100 $3.37 p/Share	30,000 Added 14.71%	174,000 Common Stock
Jul 20 2022	SELL Open market or private sale	$150,000 $30.0 p/Share	5,000 Reduced 3.36%	144,000 Common Stock
Jul 20 2022	BUY Grant, award, or other acquisition	$7,850 $1.57 p/Share	5,000 Added 3.25%	149,000 Common Stock
Jun 21 2022	SELL Open market or private sale	$124,226 $24.89 p/Share	4,991 Reduced 3.35%	144,000 Common Stock
Apr 15 2022	SELL Bona fide gift	-	7,777 Reduced 4.96%	148,991 Common Stock
Feb 22 2022	BUY Grant, award, or other acquisition	-	67,000 Added 29.94%	156,768 Common Stock
Feb 17 2022	SELL Open market or private sale	$96,077 $31.93 p/Share	3,009 Reduced 3.24%	89,768 Common Stock
Feb 16 2022	SELL Open market or private sale	$157,700 $31.54 p/Share	5,000 Reduced 5.11%	92,777 Common Stock
Feb 16 2022	BUY Exercise of conversion of derivative security	$7,650 $1.53 p/Share	5,000 Added 4.86%	97,777 Common Stock
Feb 02 2022	SELL Open market or private sale	$172,600 $34.52 p/Share	5,000 Reduced 5.11%	92,777 Common Stock
Feb 02 2022	BUY Exercise of conversion of derivative security	$7,650 $1.53 p/Share	5,000 Added 4.86%	97,777 Common Stock
Jan 19 2022	SELL Open market or private sale	$175,300 $35.06 p/Share	5,000 Reduced 5.11%	92,777 Common Stock
Jan 19 2022	BUY Exercise of conversion of derivative security	$7,650 $1.53 p/Share	5,000 Added 4.86%	97,777 Common Stock
Jan 05 2022	SELL Open market or private sale	$187,300 $37.46 p/Share	5,000 Reduced 5.11%	92,777 Common Stock
Jan 05 2022	BUY Exercise of conversion of derivative security	$7,650 $1.53 p/Share	5,000 Added 4.86%	97,777 Common Stock

Phillip Pang

EVP & Chief Medical Officer

San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VIR shares.

Notify only if

Value

Insider Trading

Get notified when an Vir Biotechnology, Inc. insider buys or sells VIR shares.

Notify only if

Operation

Value

Type

News

Receive news related to Vir Biotechnology, Inc.

Track Activities on VIR

Account